Authors:
Pruschy, M
Rocha, S
Zaugg, K
Tenzer, A
Hess, C
Fisher, DE
Glanzmann, C
Bodis, S
Citation: M. Pruschy et al., Key targets for the execution of radiation-induced tumor cell apoptosis: The role of p53 and caspases, INT J RAD O, 49(2), 2001, pp. 561-567
Authors:
Tenzer, A
Zingg, D
Rocha, S
Hemmings, B
Fabbro, D
Glanzmann, C
Schubiger, PA
Bodis, S
Prusch, M
Citation: A. Tenzer et al., The phosphatidylinositide 3 '-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C, CANCER RES, 61(22), 2001, pp. 8203-8210
Authors:
Zaugg, K
Rocha, S
Resch, H
Hegyi, I
Oehler, C
Glanzmann, C
Fabbro, D
Bodis, S
Pruschy, M
Citation: K. Zaugg et al., Differential p53-dependent mechanism of radiosensitization in vitro and invivo by the protein kinase C-specific inhibitor PKC412, CANCER RES, 61(2), 2001, pp. 732-738
Authors:
Rocha, S
Soengas, MS
Lowe, SW
Glanzmann, C
Fabbro, D
Winterhalter, K
Bodis, S
Pruschy, M
Citation: S. Rocha et al., Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance ofthe cytochrome c-mediated caspase-9 death pathway, CELL GROWTH, 11(9), 2000, pp. 491-499
Citation: K. Zaugg et S. Bodis, Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?, RADIOTH ONC, 55(2), 2000, pp. 95-99
Authors:
Pruschy, M
Wirbelauer, C
Glanzmann, C
Bodis, S
Krek, W
Citation: M. Pruschy et al., E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53, CELL GROWTH, 10(3), 1999, pp. 141-146
Authors:
Hardenbergh, PH
Hahnfeldt, P
Hlatky, L
Takemoto, C
Shimamura, A
McGill, G
Fung, CY
Bodis, S
Fisher, DE
Citation: Ph. Hardenbergh et al., Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death, INT J RAD O, 43(3), 1999, pp. 601-605
Authors:
Pruschy, M
Resch, H
Shi, YQ
Aalame, N
Glanzmann, C
Bodis, S
Citation: M. Pruschy et al., Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells, BR J CANC, 80(5-6), 1999, pp. 693-698